期刊文献+

胸腔积液腺苷脱氨酶检测诊断价值的研究 被引量:1

Diagnostic Value of ADA for Pleural Effusion
下载PDF
导出
摘要 目的探讨胸水中腺苷脱氨酶(ADA)的检测在鉴别结核性、漏出性及恶性胸水方面的临床诊断价值。方法收集患者胸水标本共93例,分为癌性胸水组、结核性胸水组和漏出性胸水组,用酶偶联连续监测法分别测定其腺苷脱氨酶(ADA)水平。结果 3组胸水中腺苷脱氨酶测定值分别为(14.24±12.90)U/L、(49.36±15.75)U/L、(10.12±7.87)U/L,其中结核性胸水中的腺苷脱氨酶(ADA)与漏出液组比较差异有统计学意义(P<0.01)。结论腺苷脱氨酶对结核性胸腔积液的鉴别诊断有较高价值,可作为一种诊断结核性胸腔积液的辅助手段。 Objective To observe the value of adenosine deaminase(ADA) in differential diagnosis of hydrothorax. Methods In this study, 93 subjects were collected in the second Xiangya hospital from Oct 2007 to Mar 2008. The patients were divided into three groups, which were the malignant hydrothorax group, the tuberculous hydrothorax group and the transudative hydrothorax group. We measured the adenosine deaminase(ADA) in pleural effusion of every patients with continuous monitored enzymatic method. Results The values of ADAin the three group were (14.24±12.90)U/I.,(49.36±15.75)U/L and (10.12±7.87)U/L, respectively. There were significant differences for the values of adenosine deaminase(ADA) among the three groups. For instance, The value of adenosine deaminase(ADA) in the tuberculous hydrothorax group was greatly different with that of the transudative hydrothorax group(P〈0.01 ). Conclusion Detection of adenosine deaminase(ADA) has highly differential diagnosis value and can be as supplementary method to diagnose tuberculous hydrothorax.
作者 李朝辉
出处 《国际检验医学杂志》 CAS 2010年第2期111-112,共2页 International Journal of Laboratory Medicine
关键词 胸腔积液 腺苷脱氨酶 诊断 pleural effusion Draminase, Adenosine Diagnosis
  • 相关文献

参考文献9

二级参考文献24

  • 1罗时文,邹国林,沈静娴,黄宗民.癌症病人腺苷脱氨酶活性测定[J].癌症,1995,14(1):30-32. 被引量:8
  • 2Light RW. Pleural effusion. N Engl J Med 2002,346(25):1971~1977. 被引量:1
  • 3Romero-Candeira S, Hernandez L, Romero-Brufao S et al. Is It Meaningful To Use BiochemicalParameters To Discriminate Between Transudative and Exudative Pleural Effusions? Chest.2002; 122:1524~ 1529. 被引量:1
  • 4Aoe K,Hiraki A,Murakami T,et al. Diagnostic significance of Interferon-γ in tuberculous pleural effusions. Chest 2003, 123:740~744. 被引量:1
  • 5Putnam, JB Jr. Malignant Pleural Effusions. Surgical Clinics of North America 2002;82(4) :867~883. 被引量:1
  • 6Yang CT,Lee MH,Lau RS,et al. Telomerase acitivity in pleural effusion :diagnostic significance. J Clin Oncol 1998,16 : 567~ 573. 被引量:1
  • 7Ferrer, J, Villarino, MA, Encabo, G, et al. Diagnostic utility of CYFRA21 - 1 ,carcinoembryonic antigen,CA 125, neuron specific enolase,and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 1999,86,1488~ 1495. 被引量:1
  • 8Antunes G,Neville E, Duffy J,et al. BTS guidelines for the management of malignant pleural effusion. Thorax, 2003; 58 (Suppl Ⅱ ) :ii29~ii38. 被引量:1
  • 9Fer rer J,Villarion MA,Tura JM,et al. Talc preparations used for pleurodesis vary markedly from one preparation to another.Chest 2001; 119:1901~5. 被引量:1
  • 10Milanez de Campos JR, Vargas FS, Werebe EC,et al. Thoracoscopy talc poudrage. A 15-year experience. Chest 2001; 119:801~6. 被引量:1

共引文献132

同被引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部